Magazine
Wednesday, May 14, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

EU doubts value of COVID-19 vaccine IP waiver as WTO wavers

Shiva Singh by Shiva Singh
1 June 2021
in Europe News
Covid-19,Vaccine,In,Researcher,Hands,,Female,Doctor,Holds,Syringe,And

Brussels (Brussels Morning) The EU is sceptical of the proposed intellectual property rights waiver for COVID-19 products including vaccines, an official of the World Trade Organisation (WTO) indicates.

Those sceptical about the proposal “continued to express doubts about the convenience of starting negotiations and asked for more time”, the official noted, as reported by RFI on Tuesday.

In addition to the EU, WTO members holding reservations about of the plan include Australia, Brazil, Japan, Norway, Singapore, South Korea, Switzerland, Taiwan and the UK.

The US, China, New Zealand and the Ukraine support the proposal to waive IP rights, but WTO agreements require the support of all member countries.

India and South Africa proposed the waiver move in October last year and have since come forward with a revised proposal. More than 60 of the WTO’s 164  member countries support the latest proposal.

Broader waiver proposed

According to the plan, the waiver would apply to vaccines, diagnostics, treatments, protective equipment and medical devices as well as their components.

The waiver would last at least three years, after which the WTO General Council should decide whether to extend it.

To date, close to two billion COVID-19 vaccine doses have been administered, about 0.3% of which were in the 29 poorest countries that account for approximately 9% of the world’s population.

Advocates of the waiver stress that the move would help increase production in developing nations. Critics are sceptical, warning that such an approach could setback future research and have other effects.

According to the official, WTO member countries are neither agreed that the waiver can help in the fight against the coronavirus pandemic nor the extent to which it would, were it to be of use.

The US remains open to continuing talks on all plans to increase production and distribution of COVID-19 vaccines, while China insists talks should proceed to the next stage.The EU focus is on the importance of increasing production and lifting export restrictions.

Related News:

  • COVID-19 —EU mobilises aid to India but rejects vaccine IP waiver
  • Parliament and WTO on track to waive COVID-19 vaccine patents
  • Parliament does U-turn on COVID-19 vaccines IP waiver
  • WTO head criticises EU’s vaccine export restrictions
Next Post

Russian and Mid-East oil majors step up as Western oil majors step back

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

12 months ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

12 months ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT